Chemically modified symmetric and asymmetric duplex RNAs: an enhanced stability to nuclease degradation and gene silencing effect.
暂无分享,去创建一个
Zhivko Zhelev | Rumiana Bakalova | H. Ohba | T. Kubo | R. Bakalova | Z. Zhelev | Hideki Ohba | Takanori Kubo
[1] Joshua T. Jones,et al. Recombinant Dicer efficiently converts large dsRNAs into siRNAs suitable for gene silencing , 2003, Nature Biotechnology.
[2] B. Sullenger,et al. Simultaneous generation of aptamers to multiple gamma-carboxyglutamic acid proteins from a focused aptamer library using DeSELEX and convergent selection. , 2007, Oligonucleotides.
[3] C. Hornyik,et al. A viral protein suppresses RNA silencing and binds silencing‐generated, 21‐ to 25‐nucleotide double‐stranded RNAs , 2002, The EMBO journal.
[4] P. Whittaker,et al. RNA interference: From gene silencing to gene-specific therapeutics , 2005, Pharmacology & Therapeutics.
[5] H. Ohba,et al. Modified 27-nt dsRNAs with dramatically enhanced stability in serum and long-term RNAi activity. , 2007, Oligonucleotides.
[6] K. Morris,et al. Lentiviral-mediated delivery of siRNAs for antiviral therapy , 2006, Gene Therapy.
[7] K. Alexander,et al. High potency silencing by single-stranded boranophosphate siRNA , 2006, Nucleic acids research.
[8] M. Stoffel,et al. Mechanisms and optimization of in vivo delivery of lipophilic siRNAs , 2007, Nature Biotechnology.
[9] Sangdun Choi,et al. Synthetic dsRNA Dicer substrates enhance RNAi potency and efficacy , 2005, Nature Biotechnology.
[10] T. Rana,et al. Visualizing a correlation between siRNA localization, cellular uptake, and RNAi in living cells. , 2004, Chemistry & biology.
[11] A. Fire,et al. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans , 1998, Nature.
[12] Paul A. Serbinowski,et al. A structural basis for discriminating between self and nonself double-stranded RNAs in mammalian cells , 2006, Nature Biotechnology.
[13] Simon W. Jones,et al. MALDI-TOF mass spectral analysis of siRNA degradation in serum confirms an RNAse A-like activity. , 2007, Molecular bioSystems.
[14] Hideyoshi Harashima,et al. RNA interference induced by siRNAs modified with 4′‐thioribonucleosides in cultured mammalian cells , 2005, FEBS letters.
[15] B. Baker,et al. Small interfering RNAs containing full 2'-O-methylribonucleotide-modified sense strands display Argonaute2/eIF2C2-dependent activity. , 2006, RNA.
[16] T. Rana,et al. siRNA function in RNAi: a chemical modification analysis. , 2003, RNA.
[17] Z. Paroo,et al. Biodistribution of phosphodiester and phosphorothioate siRNA. , 2004, Bioorganic & medicinal chemistry letters.
[18] M. Manoharan. RNA interference and chemically modified small interfering RNAs. , 2004, Current opinion in chemical biology.
[19] Angela N. Brooks,et al. Structural Basis for Double-Stranded RNA Processing by Dicer , 2006, Science.
[20] David R Corey,et al. RNA interference in mammalian cells by chemically-modified RNA. , 2003, Biochemistry.
[21] Kazunori Kataoka,et al. Lactosylated poly(ethylene glycol)-siRNA conjugate through acid-labile beta-thiopropionate linkage to construct pH-sensitive polyion complex micelles achieving enhanced gene silencing in hepatoma cells. , 2005, Journal of the American Chemical Society.
[22] Anastasia Khvorova,et al. Induction of the interferon response by siRNA is cell type- and duplex length-dependent. , 2006, RNA.
[23] T. Tuschl,et al. Functional anatomy of siRNAs for mediating efficient RNAi in Drosophila melanogaster embryo lysate , 2001, The EMBO journal.
[24] Y. Baba,et al. Antisense inhibition of Bcr‐Abl/c‐Abl synthesis promotes telomerase activity and upregulates tankyrase in human leukemia cells1 , 2004, FEBS letters.
[25] K. Taira,et al. Functional gene-discovery systems based on libraries of hammerhead and hairpin ribozymes and short hairpin RNAs. , 2005, Molecular bioSystems.
[26] Mark E. Davis,et al. Functional polarity is introduced by Dicer processing of short substrate RNAs , 2005, Nucleic acids research.
[27] K. Ui-Tei,et al. Guidelines for the selection of highly effective siRNA sequences for mammalian and chick RNA interference. , 2004, Nucleic acids research.
[28] A. Butte,et al. Creation and implications of a phenome-genome network , 2006, Nature Biotechnology.
[29] Matthias John,et al. Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs , 2004, Nature.
[30] J. Couzin. Small RNAs Make Big Splash , 2002, Science.
[31] T. Tuschl,et al. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells , 2001, Nature.
[32] Y. Yuzawa,et al. A Small Interfering RNA Targeting Vascular Endothelial Growth Factor as Cancer Therapeutics , 2004, Cancer Research.
[33] M. Eccles,et al. Conjugate for efficient delivery of short interfering RNA (siRNA) into mammalian cells , 2004, FEBS letters.
[34] Keith Bowman,et al. Potent and persistent in vivo anti-HBV activity of chemically modified siRNAs , 2005, Nature Biotechnology.
[35] T. Park,et al. Intracellular siRNA delivery system using polyelectrolyte complex micelles prepared from VEGF siRNA-PEG conjugate and cationic fusogenic peptide. , 2007, Biochemical and biophysical research communications.
[36] J. Walder,et al. Substrate specificity and kinetics of degradation of antisense oligonucleotides by a 3' exonuclease in plasma. , 1991, Antisense research and development.
[37] Judy Lieberman,et al. RNA interference targeting Fas protects mice from fulminant hepatitis , 2003, Nature Medicine.
[38] Henning Urlaub,et al. Single-Stranded Antisense siRNAs Guide Target RNA Cleavage in RNAi , 2002, Cell.
[39] Matthias John,et al. Steroid and lipid conjugates of siRNAs to enhance cellular uptake and gene silencing in liver cells. , 2004, Bioorganic & medicinal chemistry letters.
[40] T. Tuschl,et al. RNA interference is mediated by 21- and 22-nucleotide RNAs. , 2001, Genes & development.
[41] Simon W. Jones,et al. RNA targeting with peptide conjugates of oligonucleotides, siRNA and PNA. , 2007, Blood cells, molecules & diseases.